BMY - Bristol-Myers Squibb Company - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BMY is currently covered by 18 analysts with an average price target of $59.88. This is a potential upside of $11.45 (23.64%) from yesterday's end of day stock price of $48.43.

Bristol-Myers Squibb Company's activity chart (see below) currently has 210 price targets and 201 ratings on display. The stock rating distribution of BMY is 21.57% BUY, 64.71% HOLD and 13.73% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.23% with an average time for these price targets to be met of 669.77 days.

Highest price target for BMY is $73, Lowest price target is $34, average price target is $58.87.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 10-Jul-2025. First documented stock forecast 22-May-2013.

Currently out of the existing stock ratings of BMY, 11 are a BUY (21.57%), 33 are a HOLD (64.71%), 7 are a SELL (13.73%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$34

$-14.44 (-29.81%)

$39

1 months 11 days ago
(10-Jul-2025)

10/13 (76.92%)

$-14.52 (-29.93%)

137

Buy

$68

$19.56 (40.38%)

3 months 29 days ago
(23-Apr-2025)

2/3 (66.67%)

$19.47 (40.12%)

18

Buy

3 months 30 days ago
(22-Apr-2025)

3/4 (75%)

$20.88 (37.88%)

652

Hold

$54

$5.56 (11.48%)

$43

4 months 10 days ago
(11-Apr-2025)

1/4 (25%)

$3.29 (6.49%)

12

Hold

$62

$13.56 (27.99%)

$52

6 months 14 days ago
(07-Feb-2025)

6/8 (75%)

$5.15 (9.06%)

48

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BMY (Bristol-Myers Squibb Company) average time for price targets to be met?

On average it took 669.77 days on average for the stock forecasts to be realized with a an average price target met ratio 67.23

Which analyst has the current highest performing score on BMY (Bristol-Myers Squibb Company) with a proven track record?

CHRIS SCHOTT

Which analyst has the most public recommendations on BMY (Bristol-Myers Squibb Company)?

Chris Schott works at JPMORGAN and has 6 price targets and 6 ratings on BMY

Which analyst is the currently most bullish on BMY (Bristol-Myers Squibb Company)?

Chris Schott with highest potential upside - $31.56

Which analyst is the currently most reserved on BMY (Bristol-Myers Squibb Company)?

Terence Flynn with lowest potential downside - -$14.44

Bristol-Myers Squibb Company in the News

The Strong Earnings Posted By Bristol-Myers Squibb (NYSE:BMY) Are A Good Indication Of The Strength Of The Business

Even though Bristol-Myers Squibb Company’s (NYSE:BMY) recent earnings release was robust, the market didn’t seem to notice. Our analysis suggests that investors might be missing some promising details. Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments that are poised to benefit.NYSE:BMY Earnings and Revenue History August 7th...

Bristol-Myers Squibb shares snap six-session losing streak

[Bristol Myers Squibb building in San Diego, CA, USA.] JHVEPhoto/iStock Editorial via Getty Images Pharmaceutical giant Bristol-Myers Squibb (NYSE:BMY [https://seekingalpha.com/symbol/BMY]) shares inched up on Friday after six consecutive sessions of fall. The stock was up 2.1% at $44.20. BMY’s shares lost nearly 11.6% in the preceding six sessions. On a year-to-date basis, they have lost...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?